441 related articles for article (PubMed ID: 17595252)
1. Outcomes and management of patients with Cushing's disease without pathological confirmation of tumor resection after transsphenoidal surgery.
Pouratian N; Prevedello DM; Jagannathan J; Lopes MB; Vance ML; Laws ER
J Clin Endocrinol Metab; 2007 Sep; 92(9):3383-8. PubMed ID: 17595252
[TBL] [Abstract][Full Text] [Related]
2. Management of Cushing's disease: outcome in patients with microadenoma detected on pituitary magnetic resonance imaging.
Prevedello DM; Pouratian N; Sherman J; Jane JA; Vance ML; Lopes MB; Laws ER
J Neurosurg; 2008 Oct; 109(4):751-9. PubMed ID: 18826366
[TBL] [Abstract][Full Text] [Related]
3. Complications after transsphenoidal surgery for patients with Cushing's disease and silent corticotroph adenomas.
Smith TR; Hulou MM; Huang KT; Nery B; de Moura SM; Cote DJ; Laws ER
Neurosurg Focus; 2015 Feb; 38(2):E12. PubMed ID: 25639314
[TBL] [Abstract][Full Text] [Related]
4. Outcomes after repeat transsphenoidal surgery for recurrent Cushing's disease.
Patil CG; Veeravagu A; Prevedello DM; Katznelson L; Vance ML; Laws ER
Neurosurgery; 2008 Aug; 63(2):266-70; discussion 270-1. PubMed ID: 18797356
[TBL] [Abstract][Full Text] [Related]
5. Transsphenoidal surgery for Cushing's disease: a review of success rates, remission predictors, management of failed surgery, and Nelson's Syndrome.
Kelly DF
Neurosurg Focus; 2007; 23(3):E5. PubMed ID: 17961026
[TBL] [Abstract][Full Text] [Related]
6. Long-term remission and recurrence rates after first and second transsphenoidal surgery for Cushing's disease: care reality in the Munich Metropolitan Region.
Dimopoulou C; Schopohl J; Rachinger W; Buchfelder M; Honegger J; Reincke M; Stalla GK
Eur J Endocrinol; 2014 Feb; 170(2):283-92. PubMed ID: 24217937
[TBL] [Abstract][Full Text] [Related]
7. Surgical management of adrenocorticotropic hormone-secreting macroadenomas: outcome and challenges in patients with Cushing's disease or Nelson's syndrome.
De Tommasi C; Vance ML; Okonkwo DO; Diallo A; Laws ER
J Neurosurg; 2005 Nov; 103(5):825-30. PubMed ID: 16304985
[TBL] [Abstract][Full Text] [Related]
8. Surgical management of Cushing's disease.
Dallapiazza RF; Oldfield EH; Jane JA
Pituitary; 2015 Apr; 18(2):211-6. PubMed ID: 25724315
[TBL] [Abstract][Full Text] [Related]
9. Update on radiation therapy in patients with Cushing's disease.
Tritos NA; Biller BM
Pituitary; 2015 Apr; 18(2):263-8. PubMed ID: 25359445
[TBL] [Abstract][Full Text] [Related]
10. Outcome of transsphenoidal surgery for Cushing's disease: a high remission rate in ACTH-secreting macroadenomas.
Fomekong E; Maiter D; Grandin C; Raftopoulos C
Clin Neurol Neurosurg; 2009 Jun; 111(5):442-9. PubMed ID: 19200645
[TBL] [Abstract][Full Text] [Related]
11. National trends, complications, and outcomes following transsphenoidal surgery for Cushing's disease from 1993 to 2002.
Patil CG; Lad SP; Harsh GR; Laws ER; Boakye M
Neurosurg Focus; 2007; 23(3):E7. PubMed ID: 17961019
[TBL] [Abstract][Full Text] [Related]
12. Long-term remission of cyclic Cushing's disease that was diagnosed and treated surgically in non-active phase.
Asano S; Ooka H; Okazaki R; Ishikawa T; Ochiai H; Nakashima M; Ide F; Hasegawa I; Miyawaki S; Nakaguchi H; Murakami M; Ogino Y; Takano K; Matsuno A
Endocr J; 2007 Jun; 54(3):407-12. PubMed ID: 17446656
[TBL] [Abstract][Full Text] [Related]
13. Influence of the fibroblast growth factor receptor 4 expression and the G388R functional polymorphism on Cushing's disease outcome.
Brito LP; Lerário AM; Bronstein MD; Soares IC; Mendonca BB; Fragoso MC
J Clin Endocrinol Metab; 2010 Oct; 95(10):E271-9. PubMed ID: 20660043
[TBL] [Abstract][Full Text] [Related]
14. Negative surgical exploration in patients with Cushing's disease: benefit of two-thirds gland resection on remission rate and a review of the literature.
Carr SB; Kleinschmidt-DeMasters BK; Kerr JM; Kiseljak-Vassiliades K; Wierman ME; Lillehei KO
J Neurosurg; 2018 Nov; 129(5):1260-1267. PubMed ID: 29219752
[TBL] [Abstract][Full Text] [Related]
15. Prospective evaluation of transsphenoidal pituitary surgery in 108 patients with Cushing's disease.
Rollin G; Ferreira NP; Czepielewski MA
Arq Bras Endocrinol Metabol; 2007 Nov; 51(8):1355-61. PubMed ID: 18209874
[TBL] [Abstract][Full Text] [Related]
16. Therapy of endocrine disease: outcomes in patients with Cushing's disease undergoing transsphenoidal surgery: systematic review assessing criteria used to define remission and recurrence.
Petersenn S; Beckers A; Ferone D; van der Lely A; Bollerslev J; Boscaro M; Brue T; Bruzzi P; Casanueva FF; Chanson P; Colao A; Reincke M; Stalla G; Tsagarakis S
Eur J Endocrinol; 2015 Jun; 172(6):R227-39. PubMed ID: 25599709
[TBL] [Abstract][Full Text] [Related]
17. Prognostic Factors of Long-Term Remission After Surgical Treatment of Cushing's Disease.
Ioachimescu AG
Endocrinol Metab Clin North Am; 2018 Jun; 47(2):335-347. PubMed ID: 29754635
[TBL] [Abstract][Full Text] [Related]
18. Late recurrences of Cushing's disease after initial successful transsphenoidal surgery.
Patil CG; Prevedello DM; Lad SP; Vance ML; Thorner MO; Katznelson L; Laws ER
J Clin Endocrinol Metab; 2008 Feb; 93(2):358-62. PubMed ID: 18056770
[TBL] [Abstract][Full Text] [Related]
19. Early post-operative ACTH and cortisol as predictors of remission in Cushing's disease.
Acebes JJ; Martino J; Masuet C; Montanya E; Soler J
Acta Neurochir (Wien); 2007; 149(5):471-7; discussion 477-9. PubMed ID: 17406780
[TBL] [Abstract][Full Text] [Related]
20. Endoscopic transsphenoidal pituitary surgery: a good and safe primary treatment option for Cushing's disease, even in case of macroadenomas or invasive adenomas.
Wagenmakers MA; Boogaarts HD; Roerink SH; Timmers HJ; Stikkelbroeck NM; Smit JW; van Lindert EJ; Netea-Maier RT; Grotenhuis JA; Hermus AR
Eur J Endocrinol; 2013 Sep; 169(3):329-37. PubMed ID: 23786985
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
